HAVN Life Sciences Inc. HAVN.CN Stock
HAVN Life Sciences Inc. Price Chart
HAVN Life Sciences Inc. HAVN.CN Financial and Trading Overview
| HAVN Life Sciences Inc. stock price | 0.03 CAD |
| Previous Close | 0.04 CAD |
| Open | 0 CAD |
| Bid | 0.03 CAD x N/A |
| Ask | 0.04 CAD x N/A |
| Day's Range | 0 - 0 CAD |
| 52 Week Range | 0 - 2 CAD |
| Volume | 0 CAD |
| Avg. Volume | 57.78K CAD |
| Market Cap | 589.54K CAD |
| Beta (5Y Monthly) | -0.502676 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.11 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
HAVN.CN Valuation Measures
| Enterprise Value | 601.79K CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.004375 |
| Price/Book (mrq) | 0.7017544 |
| Enterprise Value/Revenue | 1.025 |
| Enterprise Value/EBITDA | -0.172 |
Trading Information
HAVN Life Sciences Inc. Stock Price History
| Beta (5Y Monthly) | -0.502676 |
| 52-Week Change | -33.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2 CAD |
| 52 Week Low | 0 CAD |
| 50-Day Moving Average | 0.04 CAD |
| 200-Day Moving Average | 0.08 CAD |
HAVN.CN Share Statistics
| Avg. Volume (3 month) | 57.78K CAD |
| Avg. Daily Volume (10-Days) | 15.94K CAD |
| Shares Outstanding | 14.74M |
| Float | 14.58M |
| Short Ratio | 0.15 |
| % Held by Insiders | 4.74% |
| % Held by Institutions | 0% |
| Shares Short | 7.68K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.050% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2022 |
| Most Recent Quarter (mrq) | January 31, 2023 |
| Next Fiscal Year End | April 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -612.59% |
| Gross Margin | 35.53% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.26% |
| Return on Equity (ttm) | -234.52% |
Income Statement
| Revenue (ttm) | 586.98K CAD |
| Revenue Per Share (ttm) | 0.08 CAD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 89.69K CAD |
| EBITDA | -3502641 CAD |
| Net Income Avi to Common (ttm) | -15710916 CAD |
| Diluted EPS (ttm) | -3.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 13.99K CAD |
| Total Cash Per Share (mrq) | 0.001 CAD |
| Total Debt (mrq) | 26.23K CAD |
| Total Debt/Equity (mrq) | 3.13 CAD |
| Current Ratio (mrq) | 2.677 |
| Book Value Per Share (mrq) | 0.057 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2609210 CAD |
| Levered Free Cash Flow (ttm) | -708919 CAD |
Profile of HAVN Life Sciences Inc.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 2800-666 Burrard Street |
| ZIP | V6C 2Z7 |
| Phone | N/A |
| Website | https://www.havnlife.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
Q&A For HAVN Life Sciences Inc. Stock
What is a current HAVN.CN stock price?
HAVN Life Sciences Inc. HAVN.CN stock price today per share is 0.03 CAD.
How to purchase HAVN Life Sciences Inc. stock?
You can buy HAVN.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for HAVN Life Sciences Inc.?
The stock symbol or ticker of HAVN Life Sciences Inc. is HAVN.CN.
Which industry does the HAVN Life Sciences Inc. company belong to?
The HAVN Life Sciences Inc. industry is Biotechnology.
How many shares does HAVN Life Sciences Inc. have in circulation?
The max supply of HAVN Life Sciences Inc. shares is 14.74M.
What is HAVN Life Sciences Inc. Price to Earnings Ratio (PE Ratio)?
HAVN Life Sciences Inc. PE Ratio is now.
What was HAVN Life Sciences Inc. earnings per share over the trailing 12 months (TTM)?
HAVN Life Sciences Inc. EPS is -3.11 CAD over the trailing 12 months.
Which sector does the HAVN Life Sciences Inc. company belong to?
The HAVN Life Sciences Inc. sector is Healthcare.